Resilience and aging

Aging Health

Volumn 3, Issue 3, 2007, Pages 309-323

  Lavretsky, Helen ^a   Irwin, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptation; Aging; Allostatic load; Resilience; Stress; Wellbeing

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM SALT; MOCLOBEMIDE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADAPTATION; AGING; ANXIETY; BEHAVIOR THERAPY; CLINICAL STUDY; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; DEPRESSION; DRUG ACTIVITY; EMOTIONALITY; ENVIRONMENTAL FACTOR; HUMAN; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; INJURY; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL WELL BEING; PSYCHOTHERAPY; REVIEW; SLEEP; SOCIAL PSYCHOLOGY; STRESS;

EID: 34250809519     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.3.3.309     Document Type: Review

References (90)

1. Vaillant GE: Aging Well. Surprising Guidepost to a Happier Life from the Landmark Harvard Study of Adult Development. Little, Brovm and Co., NY, USA, 373 (2002).
2. Rowe JW, Kahn RL: Successful Aging. Dell Publishing, NY, USA, 265 (1999).
3. Depp, CA, Jeste DV: Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am. J. Geriatr. Psychiatry 14(1), 6-20 (2006).
4. Peel NM, McClure RJ, Bartlett HP: Behavioral determinants of healthy aging. Am. J. Prev. Med. 28(3), 298-304 (2005).
5. Connor KM, Zhang W: Resilience: determinants, measurements, and treatment responsiveness. CNS Spectrums 11(10 Suppl. 12), 5-12 (2006).
6. McEwen BS: The End Of Stress As We Know It. Joseph Henry Press, Washington DC, USA, 239 (2004).
7. Yehuda R, Golier JA, Tischler L, et al.: Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J. Psychiatr. Res. 41, 435-445 (2006).
8. Ahern NR, Kiehl EM, Sole ML, Byers J: A review of instruments measuring resilience. Issues Compr. Pediatr. Nurs. 29(2), 103-125 (2006).
9. Tusaie K, Dyer J: Resilience: a historical review of the construct. Holist. Nurs. Pract. 18, 3-8 (2004).
10. Jacelon CS: The trait and process of resilience. J. Adv. Nurs. 25, 123-129 (1997).
11. Olsson CA, Bond L, Burns JM, Vella-Brodrick DA, Sawyer SM: Adolescent resilience: a concept analysis. J. Adolesc. 26, 1-11 (2003).
12. Wagnild GM, Young HM: Development and psychometric evaluation of the Resilience Scale. J. Nurs. Meas. 1, 165-178 (1993).
13. Mangi HK, Duman RS: Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol. Bull. 35(2), 5-49 (2001).
14. Ryff CD, Singer BH: Flourishing under fire: resilience as a prototype of challenged thriving. In: Flourishing: Positive Psychology and the Life Well-Lived. Keyes CL, Haidt J (Eds). American Psychological Association, Washington DC, USA, 15-36 (2003).
15. Ryff CD, Keyes CL: The structure of psychological well-being revisited. J. Pers. Soc. Psychol. 69(4), 719-727 (1995).
16. Richardson GE: The metatheory of resilience and resiliency. J. Clin. Psychol. 58(3), 307-321 (2002).
17. Fredrickson BL: The broaden-and-build theory of positive emotions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1449), 1367-1378 (2004).
18. Tugade MM, Fredrickson BL, Barrett LF: Psychological resilience and positive emotional granularity: examining the benefits of positive emotions coping and health. J. Pers. 72(6), 1161-1190 (2004).
19. Werner EE: The children of Kaul: resiliency and recovery in adolescence and adulthood. J. Adolesc. Health 13, 262-258 (1992).
20. Block J, Kremen AM: IQ and ego-resiliency: conceptual and empirical connections and separateness. J. Pers. Soc. Psychol. 70(2), 349-361 (1996).
21. Atchley RC: Continuity and Adaptation in Aging. Creating Positive Experience. John Hopkins University Press, MA, USA, 214 (1999).
22. Jopp D, Rott C: Adaptation in very old age: exploring the role of resources, beliefs, and attitudes for centenarians' happiness. Psychol. Aging 21(2), 266-280 (2006).
23. Nygren B, Alex L, Jonsen E, Gustafson Y, Norberg A, Lundman B: Resilience, sense of coherence, purpose in life and self-transcendence in relation to perceived physical and mental health among the oldest old. Aging Ment. Health 9(4), 354-362 (2005).
24. Montross LP, Depp C, Daly J et al.: Correlates of self-rated successful aging among community-dwelling older adults. Am. J. Geriatr. Psychiatry 14(1), 43-51 (2006).
25. Ryff CD, Dienberg Love G, Urry HL et al.: Psychological well-being and ill-being: do they have distinct or mirrored biological correlates? Psychother. Psychosom. 75(2), 85-95 (2006).
26. Ryff CD, Singer BH, Dienberg Love G: Positive health: connecting well-being with biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1449), 1383-1394 (2004).
27. Rubin RT, Poland RE, Lesser IM: Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch. Gen. Psychiatry 44, 328-336 (1987).
28. Brown ES, Verghese FP, McEwen BS: Association of depression with medical illness: does cortisol play a role? Biol. Psychiatry 55, 1-9 (2004).
29. Hughes JW, Watkins L, Blumenthal JA: Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J. Psychosom. Res. 57, 353-358 (2004).
30. Polk DE, Cohen S, Doyle WJ: State and trait affect as predictors of salivary, cortisol in healthy adults. Psychoneuroendocrinology 30, 261-272 (2005).
31. Markovitz JH, Matthews KA, Wing RR, Kuller LH, Meilahn EN: Psychological, biological and health behavior predictors of blood pressure changes in middle-age women. J. Hypertens. 9, 399-406 (1991).
32. Barefoot JC, Heltmann BL, Helms MJ, Williams RB, Surwit RS, Siegler IC: Symptoms of depression and changes in body weight from adolescense to mid-life. Int. J. Obes. Relat. Metab. Disord. 22, 688-694 (1998).
33. Ahlberg AC, Ljung T, Rosmond R: Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Psychiatr. Res. 112, 101-110 (2002).
34. Schuck P: Glycated hemoglobin as a physiological measure of stress and its relation to some psychological stress indicators. Behav. Med. 24, 89-94 (1998).
35. Räikkönen R, Matthews KA, Kuller LH, Reiber C, Burher CH: Anger, hostility and visceral adipose tissue in healthy post-menopausal women. Metabolism 489, 1146-1151 (1999).
36. Koenen KC: Developmental epidemiology of PTSD. Ann. NY Acad. Sci. 1071, 255-266 (2006).
37. Golier JA, Harvey PD, Legge J, Yehuda R: Memory performance in older trauma survivors: implications for the longitudinal course of PTSD. Ann. NY Acad. Sci. 1071, 54-66 (2006).
38. Miller MM, McEwen BS: Establishing an agenda for translocation research on PTSD. Ann. NY Acad. Sci. 1071, 294-312 (2006).
39. Sterling P, Eyer J: Allostasis: a new paradigm to explain arousal pathology. In: Handbook of Life Stress, Cognition, and Health. Fisher S, Reason J (Eds). John Wiley & Sons, NY, USA, 629-649 (1988).
40. McEwen BS: Sex, stress and the hippocampus: allostasis load and the aging process. Neurobiol. Aging 23, 921-939 (2002)
41. Seeman TE, MCEwen BS, Rowe JW, Singer BH: Allostatic load a a marker of cumulative biological risk: McArthur studies of successful aging. Proc. Natl Acad. Sci. USA 98, 4770-4775 (2001).
42. Bremner JD, Licinio J, Darnell A et al.: Elevated CSF corticotrophin-releasing hormone levels and adrenocortical activity in combat veterans with post-traumatic stress disorder. Am. J. Psychiatry 154, 624-629 (1997).
43. Charney DS: Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry. 161(2), 195-216 (2004).
44. Charney DS, Manji HK: Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE 2004(225), re5 (2004).
45. Karlamangla AS, Singer BH, McEwen, BS, Rowe JW, Seeman TE: Allostatic lead as a predictor of functional decline. MacArthur studies of successful aging. J. Clin. Epidemiol. 55, 696-710 (2002).
46. McEwen BS, Stellar E: Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 153(18), 2093-2101 (1993).
47. Black S, Humphrey JH, Niven JS: Inhibition of the Mantoux reaction by direct suggestion under hypnosis. Br. Med. J. 1(5346), 1649-1652 (1963).
48. Ershler WB: Interleukin-6: a cytokine for gerontologists. J. Am. Geriatr. Soc. 41(2), 176-181 (1993).
49. Ferrucci L, Harris TB, Guralnik JM et al.: Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47(6), 639-646 (1999).
50. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl Acad. Sci. USA 100(15), 9090-9095 (2003).
51. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp. Gerontol. 39(5), 687-699 (2004).
52. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128(2), 127-137 (1998).
53. Harris TB, Ferrucci L, Tracy RP et al.: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106(5), 505-512 (1999).
54. Friedman EM, Hayney M, Love GD, Singer BH, Ryff CD: Serum interleukin-6 and soluble IL-6 receptors are modulated by psychological well-being in aging women. 63rd Annual Scientific Meeting of the American Psychosomatic Society. Vancouver, British Columbia, Canada, 2-5 March 2005.
55. Lavretsky H: Stress and depression in informal family caregivers of patients with Alzheimer's disease. Aging Health 1(1), 117-133 (2005).
56. Marks NF: Does it hurt to care? Caregiving, work-family conflict, and midlife well-being. J. Marriage Fam. 60, 951-966 (1998).
57. Costello FJ, Pine DS, Hammen C et al.: Development and natural history of mood disorders. Biol. Psychiatry 52, 529-542 (2002).
58. Caspi A, Sugden K, Miffitt TE et al.: Influence of life stress on depression: moderation by a polymorphism in the 5HTT gene. Science 301, 386-389 (2003).
59. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB: Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry. 52(12), 1048-1060 (1995).
60. Rodgers B: Models of stress, vulnerability and affective disorder. J. Affect. Disord. 21(1), 1-13 (1991).
61. Davidson RJ: Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am. Psychol. 55(11), 1196-1214 (2000).
62. Davidson JR: Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 51(1), 68-80 (2002).
63. Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL: Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol. Psychiatry 29, 575-584 (1991).
64. van Cauter E, Leproult R, Kupfer DJ: Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81(7), 2468-2473 (1996).
65. van Cauter E, Leprouit R, Plat L: Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. J. Am. Med. Assoc. 284, 861-868 (2000).
66. McEwen BS: Allostasis, allostatic load and the aging nervous system: role of excitatory aminoacids and excitotoxicity. Neurochem. Res. 25, 1219-1231 (2000).
67. Plotsky PM, Owens MJ, Nemeroff CB: Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21, 293-307 (1998).
68. Zorilla EP, Luborsky L, McKay JR et al.: The relationship of depression and stressors to immunological assays: a meta-analytical review. Brain Behav. Immun. 15(3), 199-226 (2001).
69. Miller GE, Cohen S, Ritchey AK: Chronic psychological stress and the regulation of proinflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 21, 531-541 (2002).
70. Connor KM, Davidson JR: Development of new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress. Anxiety 18, 76-82 (2003).
71. Sheehan DV: The Anxiety Disease. Charles Scribner Sons, NY, USA (1983).
72. Waite PJ, Richardson GE: Determining the efficacy of resiliency training in the work site. J. Allied Health 33(3), 178-183 (2004).
73. Fava GA: Well-being therapy: conceptual and technical issues. Psychother. Psychosom. 68(4), 171-179 (1999).
74. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S: Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am. J. Psychiatry. 161(10), 1872-1876 (2004).
75. Fava GA, Ruini C, Rafanelli C et al.: Well-being therapy of generalized anxiety disorder. Psychother. Psychosom. 74(1), 26-30 (2005).
76. Ruini C, Belaise C, Brombin C, Caffo E, Fava GA: Well-being therapy in school settings: a pilot study. Psychother. Psychosom. 75(6), 331-336 (2006).
77. Miller GE, Cohen S: Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol. 20(1), 47-63 (2001).
78. Irwin M, Pike J, Oxman M: Shingles immunity and health functioning in the elderly: Tai Chi Chih as a behavioral treatment. Evid. Based Complement. Alternat. Med. 1(3), 223-232 (2004).
79. Irwin MR, Olmstead R, Oxman MN: Augmenting immune responses to Varicella zoster virus in older adults: a randomised controlled trial of Tai-Chi. J. Am. Geriatr. Soc. (2007) (In Press).
80. Motivala SJ, Sollers J, Thayer J, Irwin MR: Tai Chi Chih acutely decreases sympathetic nervous system activity in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 61(11), 1177-1180 (2006).
81. Lutgendorf SK, Antoni MH, Kumar M, Schneiderman N: Changes in cognitive coping strategies predict EBV-antibody titre change following a stressor disclosure induction. J. Psychosom. Res. 38(1), 63-78 (1994).
82. Segerstrom SC, Taylor SE, Kemeny ME, Fahey JL: Optimism is associated with mood, coping, and immune change in response to stress. J. Pers. Soc. Psychol. 74(6), 1646-1655 (1998).
83. Fawzy FI, Kemeny ME, Fawzy NW et al.: A structured psychiatric intervention for cancer patients: IL Changes over time in immunological measures. Arch. Gen. Psychiatry. 47, 729-735 (1990).
84. Irwin MR, Pike JL, Cole JC, Oxman MN: Effects of a behavioral intervention, Tai Chi Chih, on Varicella-zoster virus specific immunity and health functioning in older adults. Psychosom. Med. 65(5), 824-830 (2003).
85. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR: Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br. J. Psychiatry 175, 17-22 (1999).
86. Davidson JR, Stein DJ, Rothbaum BO, Pedersen R, Tain XW, Musgnung J: Resilience as a predictor of remission in PTSD patients treated with venlafaxine XR or placebo. Poster presented at: Annual Meeting of the Anxiety Disorders of America. Miami, FL, USA, 23-26 March 2006.
87. O'Brien SM, Scott LV, Dinan TG: Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol. 19(6), 397-403 (2004).
88. Maes M: The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 16(1), 95-103 (2001).
89. Raison CL, Miller AH: The neuroimmunology of stress and depression. Semin. Clin. Neuropsychiatry 6(4), 277-294 (2001).
90. Charney DS, Reynolds CF, Lewis L et al.: Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch. Gen. Psychiatry. 60(7), 664-672 (2003).